Indivior Pharmaceuticals, Inc. (E7P)
XDUS
Closed
Aug 24, 2026
Day's Range
30.6052 wk Range
14.30Overview - E7P - Indivior Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
156.00M
P/E (Trailing)
‪18.33‬
PEG Ratio
‪0.03‬
Price / Book
‪-17.53‬
EV / EBITDA
‪0.50‬
Profitability
Gross Margin
‪85.42%‬
Profit Margin
‪80.14%‬
Operating Margin
‪22.92%‬
Return on Assets
‪17.47%‬
Return on Equity
‪-212.12%‬
Ownership
Shares Outstanding
118.00M
Price stats
50-Day Avg
‪34.10‬
200-Day Avg
‪26.88‬
Peers - E7P - Indivior Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- E7PXDUSIndivior Pharmaceuticals, Inc.+53.57%52-week change18.33P/E (Trailing)‪80.14%‬Profit Margin
- IP40XDUSInnoCan Pharma Corporation+90.63%52-week change-5.40P/E (Trailing)‪89.92%‬Profit Margin
- PA8XDUSPaion AG+79.83%52-week change-0.74P/E (Trailing)‪94.10%‬Profit Margin
- 6CWXDUSCharlottes Web Holdings Inc.+74.64%52-week change-1.32P/E (Trailing)‪43.48%‬Profit Margin
- 20MPXDUSMountain Valley MD Holdings Inc.+68.45%52-week change-3.55P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+63.90%52-week change—P/E (Trailing)—Profit Margin
- 4KF0XDUSGlass House Brands Inc.+53.83%52-week change-14.00P/E (Trailing)‪42.28%‬Profit Margin
Profile Summary - E7P - Indivior Pharmaceuticals, Inc.
About
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on treating substance use disorders and related mental health conditions. The company concentrates on evidence-based therapies for opioid use disorder, including long-acting injectable and sublingual formulations designed to support adherence…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
